SPX3,640.71-78.33 -2.11%
DIA292.22-4.51 -1.52%
IXIC10,737.51-314.13 -2.84%

Caladrius Biosciences Secures Shareholder Approval for Cend Therapeutics Merger

Caladrius Biosciences Secures Shareholder Approval for Cend Therapeutics Merger

MT Newswires · 09/14/2022 06:33

Please log in to view news